Merck & Co. Inc. (MRK)
NYSE: MRK
· Real-Time Price · USD
84.56
1.80 (2.17%)
At close: Aug 15, 2025, 2:14 PM
Merck & Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 30, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Animal Health segment Revenue | 5.88B | 53.58B | 5.55B | 5.57B | 4.7B | 4.39B | 4.21B | 35.39B | 35.15B | 34.78B | 6.2B | 6.6B | 6.41B | 41.29B |
| Animal Health segment Revenue Growth | -89.03% | +865.46% | -0.32% | +18.39% | +7.06% | +4.30% | -88.10% | +0.68% | +1.06% | +461.45% | -6.08% | +2.87% | -84.47% | n/a |
| Pharmaceutical segment Revenue | 57.4B | 5.63B | 52.01B | 42.75B | 43.02B | 696M | 393M | 4.73B | 4.66B | 4.72B | 36.04B | 37.44B | 40.6B | 53.94B |
| Pharmaceutical segment Revenue Growth | +920.44% | -89.18% | +21.64% | -0.62% | +6081.18% | +77.10% | -91.69% | +1.63% | -1.27% | -86.92% | -3.73% | -7.79% | -24.73% | n/a |
| Other Segments Revenue | 891M | 907M | 1.73B | 382M | 23M | 41.75B | 37.69B | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Segments Revenue Growth | -1.76% | -47.51% | +352.36% | +1560.87% | -99.94% | +10.78% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2024 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asia Pacific Revenue | 3.06B | 3.61B | 2.41B | 2.86B | 2.94B | 2.91B | 17.42B | 3.92B | 3.82B | 3.95B | 3.85B | 20.39B | 20.5B | 20.23B |
| Asia Pacific Revenue Growth | -15.38% | +50.15% | -15.96% | -2.68% | +1.17% | -83.30% | +344.72% | +2.57% | -3.32% | +2.76% | -81.14% | -0.50% | +1.33% | n/a |
| China Revenue | 5.49B | 5.19B | 4.38B | 3.62B | 3.21B | 2.18B | 4.34B | 10.95B | 10.68B | 13.17B | 13.14B | 12.99B | 4.83B | 13.5B |
| China Revenue Growth | +5.84% | +18.57% | +20.81% | +13.00% | +46.84% | -49.64% | -60.40% | +2.58% | -18.95% | +0.26% | +1.15% | +168.67% | -64.18% | n/a |
| Emea Revenue | 14.04B | 14.49B | 13.34B | 13.6B | 12.71B | 12.21B | 11.48B | 2.85B | 2.67B | 3.47B | 4.04B | 5.1B | n/a | 3.77B |
| Emea Revenue Growth | -3.12% | +8.64% | -1.90% | +7.03% | +4.04% | +6.40% | +303.30% | +6.47% | -22.99% | -14.17% | -20.74% | n/a | n/a | n/a |
| Japan Revenue | 3.28B | 3.63B | 2.73B | 3.38B | 3.58B | 3.21B | 3.12B | 2.15B | 2.82B | 3.15B | 3.2B | 8.78B | n/a | 8.5B |
| Japan Revenue Growth | -9.62% | +33.13% | -19.25% | -5.78% | +11.55% | +2.88% | +44.87% | -23.66% | -10.41% | -1.62% | -63.53% | n/a | n/a | n/a |
| Latin America Revenue | 3.46B | 2.58B | 2.21B | 2.27B | 2.47B | 2.42B | 2.34B | 1.46B | 1.99B | 1.42B | 1.55B | n/a | n/a | n/a |
| Latin America Revenue Growth | +33.97% | +17.04% | -2.99% | -7.90% | +2.24% | +3.25% | +60.54% | -26.64% | +39.96% | -8.75% | n/a | n/a | n/a | n/a |
| International Revenue | 2.56B | 2.57B | 1.22B | 1.23B | 1.61B | 1.15B | 1.42B | 18.48B | 17.52B | 17.07B | 18.25B | n/a | n/a | n/a |
| International Revenue Growth | -0.35% | +110.32% | -0.65% | -23.47% | +39.77% | -19.20% | -92.30% | +5.47% | +2.62% | -6.44% | n/a | n/a | n/a | n/a |
| United States Revenue | 32.28B | 27.21B | 22.43B | 21.03B | 20.32B | 18.21B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| United States Revenue Growth | +18.64% | +21.32% | +6.65% | +3.45% | +11.60% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 2.65B | 2.55B | 2.86B | 2.73B | 2.74B | 2.48B | 2.8B | 2.52B | 2.7B | 2.48B | 2.69B | 2.52B | 2.51B | 2.32B | 2.83B | 2.34B | 2.28B | 2.19B | 3.08B | 2.06B | 2.08B | 2.56B | 2.89B | 2.59B | 2.71B | 2.42B | 2.64B | 2.44B | 2.51B | 2.51B | 2.58B | 2.46B | 2.5B | 2.47B | 2.59B | 2.39B | 2.46B | 2.32B | 2.62B | 2.47B | 2.62B | 2.6B |
| Selling, General, and Administrative Revenue Growth | +3.80% | -10.89% | +4.87% | -0.29% | +10.31% | -11.45% | +11.31% | -6.77% | +9.00% | -7.74% | +6.63% | +0.32% | +8.14% | -17.92% | +21.15% | +2.41% | +4.30% | -29.11% | +49.76% | -1.20% | -18.40% | -11.56% | +11.59% | -4.54% | +11.84% | -8.25% | +8.19% | -2.59% | 0.00% | -2.75% | +4.88% | -1.64% | +1.13% | -4.67% | +8.36% | -2.64% | +6.04% | -11.36% | +5.78% | -5.79% | +0.88% | n/a |
| Research and Development Revenue | 4.05B | 3.62B | 4.58B | 5.86B | 3.5B | 3.99B | 9.63B | 3.31B | 13.32B | 4.28B | 3.77B | 4.4B | 2.8B | 2.58B | 3.07B | 2.44B | 4.32B | 2.41B | 5.84B | 3.35B | 2.08B | 2.21B | 2.55B | 3.2B | 2.19B | 1.93B | 2.21B | 2.07B | 2.27B | 3.2B | 2.28B | 4.41B | 1.78B | 1.83B | 4.65B | 1.66B | 2.15B | 1.66B | 1.8B | 1.5B | 1.67B | 1.74B |
| Research and Development Revenue Growth | +11.79% | -21.01% | -21.80% | +67.49% | -12.32% | -58.53% | +191.11% | -75.17% | +211.53% | +13.27% | -14.19% | +57.22% | +8.62% | -16.04% | +25.48% | -43.42% | +79.15% | -58.68% | +74.29% | +60.62% | -5.61% | -13.30% | -20.47% | +46.37% | +13.36% | -12.78% | +7.06% | -9.06% | -28.85% | +40.11% | -48.31% | +147.64% | -2.62% | -60.64% | +179.39% | -22.64% | +29.66% | -7.73% | +19.87% | -10.18% | -3.86% | n/a |